Atlas Trials

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Clinical trial NCT05741385 · COMPLETED

Trial details

NCT number
NCT05741385
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2023-10-10
Primary completion
2024-08-09
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.